Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Insulin treatment often causes the blood glucose levels to fall too low. The body usually
responds to low blood glucose levels by releasing hormones which act against the insulin to
help correct the low blood glucose levels. However, this hormone response can be altered in
people with diabetes. Currently there are no therapeutic agents that can be used to improve
the recovery from hypoglycemia (low blood sugar). The aim of this study is to determine
whether a formoterol inhaler can be used to improve and accelerate the recovery from
hypoglycemia in patients with type 1 diabetes.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)